These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of the new ARCHITECT anti-HCV screening test under routine laboratory conditions. Berger A; Rabenau H; Allwinn R; Doerr HW J Clin Virol; 2008 Oct; 43(2):158-61. PubMed ID: 18635393 [TBL] [Abstract][Full Text] [Related]
4. [Retrospective study of the value of the RIBA-3 test in 68 patients with discordant serologies with regard to hepatitis C obtained with third generation ELISA tests. Is there still a value in RIBA-3?]. Cecille A; Wendling MJ; Panabieres O; Gut JP Pathol Biol (Paris); 1999 May; 47(5):508-11. PubMed ID: 10418029 [TBL] [Abstract][Full Text] [Related]
5. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection. Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268 [TBL] [Abstract][Full Text] [Related]
6. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Pawlotsky JM; Lonjon I; Hezode C; Raynard B; Darthuy F; Remire J; Soussy CJ; Dhumeaux D Hepatology; 1998 Jun; 27(6):1700-2. PubMed ID: 9620345 [TBL] [Abstract][Full Text] [Related]
7. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ]. Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O; Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity of a modified version of the ARCHITECT Anti-HCV test in detecting samples with immunoblot-confirmed, low-level antibody to hepatitis C virus. Echevarría JM; Avellón A; Jonas G; Hausmann M; Vockel A; Kapprell HP J Clin Virol; 2006 Apr; 35(4):368-72. PubMed ID: 16406797 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of three commercially available hepatitis C virus antibody detection assays under the conditions of a clinical virology laboratory. Zachary P; Ullmann M; Djeddi S; Meyer N; Wendling MJ; Schvoerer E; Stoll-Keller F; Gut JP J Clin Virol; 2005 Nov; 34(3):207-10; discussion 216-8. PubMed ID: 16122975 [TBL] [Abstract][Full Text] [Related]
10. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody. Dussaix E; Charnaux N; Laurent-Puig P; Chopineau S; Laurian Y; Buffet C J Clin Microbiol; 1994 Sep; 32(9):2071-5. PubMed ID: 7529247 [TBL] [Abstract][Full Text] [Related]
11. [Anti-HCV serology for screening, diagnosis and surveillance of hepatitis C: role of the immunoblot]. Dubois F; Barin F; Goudeau A Ann Biol Clin (Paris); 1998; 56(4):417-26. PubMed ID: 9754277 [TBL] [Abstract][Full Text] [Related]
12. [Use of combined detection of hepatitis C virus core antigen and antibodies to reduce the serological window-phase]. Hmaïed F; Ben Mamou M; Arrouji Z; Slim A; Ben Redjeb S Pathol Biol (Paris); 2007 Mar; 55(2):121-6. PubMed ID: 16631320 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection. Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure. Bes M; Esteban JI; Casamitjana N; Piron M; Quer J; Cubero M; Puig L; Guardia J; Sauleda S Transfusion; 2009 Jul; 49(7):1296-305. PubMed ID: 19222816 [TBL] [Abstract][Full Text] [Related]
15. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients. Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955 [TBL] [Abstract][Full Text] [Related]
16. Validation of a strategy for HCV antibody testing with two enzyme immunoassays in a routine clinical laboratory. Vermeersch P; Van Ranst M; Lagrou K J Clin Virol; 2008 Aug; 42(4):394-8. PubMed ID: 18448386 [TBL] [Abstract][Full Text] [Related]
17. [Hepatitis C virus screening: performances characteristics of a commercial automated chemiluminescent microparticle immunoassay (CMIA-ARCHITECT anti-HCV)]. Petitjean Lecherbonnier J; Gouarin S; Dina J; Vabret A; Freymuth F Pathol Biol (Paris); 2007 Dec; 55(10):512-20. PubMed ID: 17959324 [TBL] [Abstract][Full Text] [Related]
18. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection. Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation on the anti-hepatitis C virus enzyme-linked immunosorbent diagnostic kits]. Zhou C; Qi Z; Gu J Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):115-7. PubMed ID: 12515185 [TBL] [Abstract][Full Text] [Related]
20. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0). Myrmel H; Navaratnam V; Asjø B J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]